[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comment & Response
March 2018

Low-Dose Atropine for Myopia Control—Reply

Author Affiliations
  • 1Department of Optometry and Visual Science, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China
  • 2Division of MR Research, Department of Radiology and Radiological Science, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 3NeuroRepair Department, Mossakowski Medical Research Centre PAS, Warsaw, Poland
  • 4Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
JAMA Ophthalmol. 2018;136(3):303-304. doi:10.1001/jamaophthalmol.2017.6641

In Reply We thank Bullimore and Berntsen for their letter. In response to their point on the 2 studies1,2 investigating low-dose (0.01%) atropine, we reply that we used the data of the first study to compare between the group receiving atropine and the control group. However, we presented data from both studies for comparisons of different concentrations of atropine in the Supplement accompanying our report (eFigure 2).